PE-backed spine company shoots for 2022 FDA approval

SHS Capital has invested in Blue Ocean Spine, a Germany-based device company seeking to expand into the U.S. in 2022.

Advertisement

Blue Ocean Spine is developing spinal cages that eliminate additional screw connections for surgeons, according to a Jan. 12 news release. The company aims to limit the number of implants required in the operating room and streamline surgeon workflow.

The implants are manufactured using 3D printing, which can provide greater cost savings over other implant materials.

SHS Capital, a German company that focuses on venture capital and private equity investments, will “assist Blue Ocean Spine with equity and our broad network,” Patrick Frohnheiser, investment manager at SHS Capital, said in the news release.

More articles on devices:
Medtronic CEO predicts AI, machine learning as ‘the new frontier for medtech’ — 4 key quotes
40 orthopedic devices receiving FDA clearance in December
Stryker, Smith+Nephew seal 1st acquisitions of 2021: 7 device company notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.